22 July 2020Muireann Bolger

LSPN Connect: artificial intelligence and IP

Artificial Intelligence (AI) offers exciting and unprecedented opportunities for life sciences and healthcare but also poses complex questions for the IP sector, as an LSPN Connect session discovered yesterday, July 21.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

ECTA: The risks of progress without a plan

3 June 2021 The implications of applying AI solutions must be carefully and fully considered before they are implemented, argues Mladen Vukmir of ECTA.

Patents

Only humans can invent, says judge in first US AI patent decision

6 September 2021 Only a human being can be legally listed on a patent as an inventor, according to a Virginia federal judge who delivered the first US ruling in the worldwide debate on the patentability of AI inventions.

Patents

EPO affirms that AI cannot invent

22 December 2021 The European Patent Office has ruled that only humans can invent, dismissing appeals looking to list an artificial intelligence as a named inventor on a patent.

Red Brand Chicken: A cautionary tale of bad faith and the EUIPO-EU General Court dynamic

Lego scores dual win at EUIPO

Armani soars to victory in eagle logo dispute at EU court

Tourism’s influence on defining the ‘relevant public’ in EUTM oppositions

UPDATED: German music rights body targets ChatGPT maker in ‘world first’

German court convicts three people of fraud over ‘misleading’ IP invoices

‘This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards

Cheese makers’ Halloumi TM appeal doesn’t cut it in UK

LSPN Connect: artificial intelligence and IP

More on this story

Editor's picks

Editor's picks

More articles